AdvaMed’s Policy Agenda is based upon four pillars and facilitated by AdvaMed Staff:
- Technology and Regulatory- Strives to improve the regulatory environment for member companies including such efforts as 510(k) reform, reauthorization of Medical Device User Fee Act (MDUFA), postmarket surveillance and enforcement, and global harmization.
- Payment and Health Policy- Influences health care delivery and reimbursement policies to facilitate access to medical products and payment supporting innovation and value creation.
- Global Strategy and Analysis- Focuses on health care, trade, and medical technology regulatory and reimbursement issues in leading and key emerging world markets, and through international organizations.
- Legal and Compliance- Advocates for a predictable legal environment and focuses on areas such as Physician Payments Sunshine, Intellectual Property, Ethics and Compliance, Vendor Access, and the Medical Device Tax.
The General Counsel’s Office also oversees certification to the AdvaMed Code of Ethics, which clarifies and distinguishes appropriate and inappropriate activity between health care professionals and MedTech company representatives.
Senior Staff Team
Mr. Vincent Forlenza, President & Chief Executive Officer, BD, Chairman of the Board, AdvaMed
Stephen J. Ubl, President & Chief Executive Officer
David H. Nexon, Senior Executive Vice President
JC Scott , Senior Executive Vice President, Government Affairs
Kenneth Mendez, Senior Executive Vice President & Chief Administrative Officer
Janet Trunzo, Senior Executive Vice President, Technology & Regulatory Affairs
Andrew Fish, Executive Director, AdvaMed Diagnostics; Senior Executive Vice President
Christopher L. White, Senior Executive Vice President, General Counsel
Donald May, Executive Vice President, Payment & Health Care Delivery Policy
Ralph F. Ives, Executive Vice President, Global Strategy & Analysis
Wanda Moebius, Senior Vice President, Public Affairs
Ashley Wallin, Executive Director & Vice President, Emerging Growth Company Council